US Stock MarketDetailed Quotes

EXAS Exact Sciences

Watchlist
  • 58.930
  • -0.470-0.79%
Close Dec 23 16:00 ET
  • 58.930
  • 0.0000.00%
Post 16:05 ET
10.91BMarket Cap-50.80P/E (TTM)

Exact Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Exact Sciences Q3 2024 Earnings Date

Currency：USDNov 5, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
716.99M
708.66M
-8.33M
Miss Est.
+14.11%
+12.78%
-1.16%
EPS
-0.18
-0.21
-0.03
Miss Est.
--
-4969.00%
-14.13%
Analyst Rating
Strong Buy

Dec 23, 2024

Exact Sciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 17 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 700.048M--
--2024/Q4-- / 694.748M--
Nov 5, 20242024/Q3708.655M / 716.988M--
Jul 31, 20242024/Q2699.264M / 690.103M--
May 8, 20242024/Q1637.524M / 626.805M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 700.048M--
--2024/Q4-- / 694.748M--
Nov 5, 20242024/Q3708.655M / 716.988M--
Jul 31, 20242024/Q2699.264M / 690.103M--
May 8, 20242024/Q1637.524M / 626.805M--

Unlock Free Earnings Estimates

Exact Sciences Earnings Reports

  • Exact Sciences | 10-Q: Q3 2024 Earnings Report

    Nov 5 17:12 ET

  • Exact Sciences | 10-Q: Q2 2024 Earnings Report

    Jul 31 17:11 ET

  • Exact Sciences | 10-Q: Q1 2024 Earnings Report

    May 8 17:07 ET

  • Exact Sciences | 10-K: FY2023 Annual Report

    Feb 21 17:12 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    New Fortress Energy
    NFE
    +21.74%
    AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
    AIPUY
    +8.49%
    Dorian LPG
    LPG
    +4.83%
    Precision Drilling
    PDS
    +2.46%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +1.94%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 23, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Cancer Research
    Cancer Research
    Intraday+1.15%